Previous
Previous

Lantern Pharma Advances Prostate Cancer Drug Development Research Collaboration with Georgetown University for LP-184, a Next-Generation, Targeted DNA-Damaging Agent

Next
Next

On the rise: Meet NTX Inno's 2020 25 Under 25